As of close of business last night, Marker Therapeutics Inc.’s stock clocked out at $0.33, down -0.85% from its previous closing price of $0.33. In other words, the price has decreased by -$0.0028 from its previous closing price. On the day, 1090353 shares were traded. MRKR stock price reached its highest trading level at $0.3750 during the session, while it also had its lowest trading level at $0.3206.
To gain a deeper understanding of MRKR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 2.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 25, 2021, initiated with a Overweight rating and assigned the stock a target price of $6.
On March 19, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $6.
Piper Sandler Downgraded its Overweight to Neutral on May 12, 2020, whereas the target price for the stock was revised from $5 to $2.50.
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.39 while its Price-to-Book (P/B) ratio in mrq is 1.21.
Stock Price History:
Over the past 52 weeks, MRKR has reached a high of $1.33, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.3852, while the 200-Day Moving Average is calculated to be 0.3779.
It appears that MRKR traded 476.87K shares on average per day over the past three months and 258.91k shares per day over the past ten days. A total of 83.60M shares are outstanding, with a floating share count of 66.66M. Insiders hold about 20.26% of the company’s shares, while institutions hold 25.10% stake in the company. Shares short for MRKR as of Oct 13, 2022 were 979.15k with a Short Ratio of 1.19M, compared to 1.25M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.17% and a Short% of Float of 1.66%.
As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.12 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.14, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.1 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.46 and -$0.53 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.47, with 3 analysts recommending between -$0.34 and -$0.72.
A total of 2 analysts have provided revenue estimates for MRKR’s current fiscal year. The highest revenue estimate was $3.5M, while the lowest revenue estimate was $1.75M, resulting in an average revenue estimate of $2.63M. In the same quarter a year ago, actual revenue was $1.24M, up 111.90% from the average estimate.